Cell Therapeutics (CTIC) shares resume trading 25% higher
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Join SI Premium – FREE
Cell Therapeutics (Nasdaq: CTIC) shares resume trading 25 percent higher.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI Corp. (UGI) halted on volatility, up 6%
- UBS flags this name, sees "significant potential for stock outperformance"
- These 2 companies are best positioned to scale in U.S. AV market
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
